Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease. (Q39284027)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Roger A. Barker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Simon R W Stott

series ordinal

1

1 reference

10 September 2017

language of work or name

English

0 references

publication date

26 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neuroscience

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1042-1056

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24372914%20AND%20SRC:MED&resulttype=core&format=json

Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice

3 March 2020

cites work

1 reference

Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease

21 January 2018

1 reference

Transcriptional control of midbrain dopaminergic neuron development

21 January 2018

1 reference

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

21 January 2018

1 reference

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death

21 January 2018

1 reference

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model

21 January 2018

1 reference

The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting

21 January 2018

1 reference

Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease.

21 January 2018

1 reference

Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease

21 January 2018

1 reference

Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons

21 January 2018

1 reference

Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease

21 January 2018

1 reference

Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP.

21 January 2018

1 reference

Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons

21 January 2018

1 reference

Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.

21 January 2018

1 reference

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

21 January 2018

1 reference

Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3.

21 January 2018

1 reference

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

Microglia as mediators of inflammatory and degenerative diseases

21 January 2018

1 reference

Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat.

21 January 2018

1 reference

Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease

21 January 2018

1 reference

Differential activation of PKC delta in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions

21 January 2018

1 reference

Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine

21 January 2018

1 reference

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites

21 January 2018

1 reference

Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death.

21 January 2018

1 reference

The genetics and neuropathology of Parkinson's disease

21 January 2018

1 reference

Activating transcription factor 3 and the nervous system

21 January 2018

1 reference

Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice

21 January 2018

1 reference

Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer

21 January 2018

1 reference

Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice

21 January 2018

1 reference

Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency.

21 January 2018

1 reference

Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model

21 January 2018

1 reference

Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons

21 January 2018

1 reference

Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy

21 January 2018

1 reference

Cell intrinsic and extrinsic factors contribute to enhance neural circuit reconstruction following transplantation in Parkinsonian mice.

21 January 2018

1 reference

21 January 2018

Physiology of microglia

1 reference

Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes

21 January 2018

1 reference

Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease

21 January 2018

1 reference

Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease

21 January 2018

1 reference

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

21 January 2018

1 reference

Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity

21 January 2018

1 reference

A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function

21 January 2018

1 reference

Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.

21 January 2018

1 reference

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

21 January 2018

1 reference

A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion

21 January 2018

1 reference

Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo

21 January 2018

1 reference

Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease

21 January 2018

1 reference

Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice

21 January 2018

1 reference

Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity

21 January 2018

1 reference

Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease

21 January 2018

1 reference

Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.

21 January 2018

1 reference

Meal patterns in rats with nigrostriatal dopamine-depleting lesions, subdiaphragmatic vagotomy, and their combination

21 January 2018

1 reference

Up-regulation of microglial CD11b expression by nitric oxide

21 January 2018

1 reference

Mechanisms of action of 6-hydroxydopamine

21 January 2018

1 reference

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

The Ki-67 protein: from the known and the unknown

21 January 2018

1 reference

Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae

21 January 2018

1 reference

Distribution of microglia in the postnatal murine nigrostriatal system

21 January 2018

1 reference

Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression

21 January 2018

1 reference

Biochemical specificity of von Economo neurons in hominoids

21 January 2018

1 reference

Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages.

21 January 2018

1 reference

Systems analysis of ATF3 in stress response and cancer reveals opposing effects on pro-apoptotic genes in p53 pathway.

21 January 2018

1 reference

Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

21 January 2018

1 reference

Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain.

21 January 2018

1 reference

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease

21 January 2018

1 reference

Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants

21 January 2018

1 reference

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

21 January 2018

1 reference